Literature DB >> 8820114

Evidence that Lp[a] contains one molecule of apo[a] and one molecule of apoB: evaluation of amino acid analysis data.

J J Albers1, H Kennedy, S M Marcovina.   

Abstract

Amino acid analysis was performed on four Lp[a] preparations to evaluate whether or not the amino acid data was consistent with Lp[a] containing one molecule of apolipoprotein[a] [apo(a)] linked to one molecule of apoB-100. Amino acid analysis was carried out in duplicate on a Beckman model 121 amino acid analyzer. Apo[a] size was determined by a high-resolution agarose gel electrophoretic method that provides an estimate of apo[a] kringle 4 repeats. When Lp[a] was assumed to contain one apo[a] and one apoB molecule per particle, the average absolute bias between the expected molar percentage of each amino acid, as based on the known sequence of apo[a] and apoB, and the obtained molar percentage ranged from 2 to 3.5%. In contrast, by assuming two molecules of apo[a] and one of apoB per Lp[a] particle, the bias between the expected and observed molar percentage ranged from 8.5% to 10%, and by assuming one apo[a] and two apoB the bias ranged from 8.8% to 11.4%. Comparison of Lp[a] concentrations, calculated from six stable amino acids and the Lp[a] composition predicted from the known sequence, was in excellent agreement (bias ranging from 0.3% to 0.9%) with the Lp[a] concentration calculated from the sum of the amino acid concentrations, when Lp[a] was assumed to contain one molecule of apo[a] and one molecule of apoB. However, there was poor agreement (7.4% to 8.4% bias) when it was assumed that Lp[a] contains two molecules of apo[a] and one molecule of apoB. These results indicate that the evaluated Lp[a] preparations contain one apo[a] per Lp[a] particle. Evaluation of amino acid analysis data provides a relatively simple approach to determine the molar ratio of apoB to apo[a] in Lp[a] and provides evidence that Lp[a] contains one molecule of apo[a] and one molecule of apoB.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8820114

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  20 in total

Review 1.  Lipoprotein(a) and coronary heart disease risk.

Authors:  S M Marcovina; R A Hegele; M L Koschinsky
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

Review 2.  Lipoprotein (a) measurements for clinical application.

Authors:  Santica M Marcovina; John J Albers
Journal:  J Lipid Res       Date:  2015-12-04       Impact factor: 5.922

3.  Antibiotics Suppress Activation of Intestinal Mucosal Mast Cells and Reduce Dietary Lipid Absorption in Sprague-Dawley Rats.

Authors:  Hirokazu Sato; Linda S Zhang; Kristina Martinez; Eugene B Chang; Qing Yang; Fei Wang; Philip N Howles; Ryota Hokari; Soichiro Miura; Patrick Tso
Journal:  Gastroenterology       Date:  2016-07-18       Impact factor: 22.682

4.  Serum LDL- and HDL-cholesterol determined by ultracentrifugation and HPLC.

Authors:  Jun Dong; Hanbang Guo; Ruiyue Yang; Hongxia Li; Shu Wang; Jiangtao Zhang; Wenxiang Chen
Journal:  J Lipid Res       Date:  2010-11-01       Impact factor: 5.922

5.  Association of Apo(a)isoform size with dyslipoproteinemia in male venous thrombosis patients.

Authors:  Marian C Cheung; John J Albers; Hal Kennedy; Hiroshi Deguchi; Darlene J Elias; Patricia M Averell; John H Griffin; Santica M Marcovina
Journal:  Clin Chim Acta       Date:  2010-05-19       Impact factor: 3.786

6.  CD36 is important for chylomicron formation and secretion and may mediate cholesterol uptake in the proximal intestine.

Authors:  Andromeda M Nauli; Fatiha Nassir; Shuqin Zheng; Qing Yang; Chun-Min Lo; Sarah B Vonlehmden; Dana Lee; Ronald J Jandacek; Nada A Abumrad; Patrick Tso
Journal:  Gastroenterology       Date:  2006-08-16       Impact factor: 22.682

Review 7.  Proteomics investigations of HDL: challenges and promise.

Authors:  Tomáš Vaisar
Journal:  Curr Vasc Pharmacol       Date:  2012-07       Impact factor: 2.719

8.  Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a).

Authors:  Margaret R Diffenderfer; Stefania Lamon-Fava; Santica M Marcovina; P Hugh R Barrett; Julian Lel; Gregory G Dolnikowski; Lars Berglund; Ernst J Schaefer
Journal:  Metabolism       Date:  2015-11-06       Impact factor: 8.694

9.  Inhibition of plasminogen activation by apo(a): role of carboxyl-terminal lysines and identification of inhibitory domains in apo(a).

Authors:  Rocco Romagnuolo; Santica M Marcovina; Michael B Boffa; Marlys L Koschinsky
Journal:  J Lipid Res       Date:  2014-01-29       Impact factor: 5.922

10.  Prevalence and determinants of elevated apolipoprotein B and dense low-density lipoprotein in youths with type 1 and type 2 diabetes.

Authors:  John J Albers; Santica M Marcovina; Giuseppina Imperatore; Beverly M Snively; Jeanette Stafford; Wilfred Y Fujimoto; Elizabeth J Mayer-Davis; Diana B Petitti; Catherine Pihoker; Larry Dolan; Dana M Dabelea
Journal:  J Clin Endocrinol Metab       Date:  2007-12-18       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.